Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2004
08/18/2004CN1521499A Polydirectional logic type microfluid control system and method thereof
08/18/2004CN1521497A Microarray biochip reflective image obtaining and analysis device and method
08/18/2004CN1521492A Sampling probe used to fabricate tissue micro array and correlative components
08/18/2004CN1521491A Fixing box for paraffin mass used to fabricate tissue micro array
08/18/2004CN1521274A System and method for detecting biological and chemical material
08/18/2004CN1521273A DNA single molecular orderly sequencing method
08/18/2004CN1521272A Novel ligand detecting method
08/18/2004CN1521271A Method for detecting target nucleic acid using affinity amplifying integrated signal group
08/18/2004CN1521270A Method for detecting specific target nucleic acid and agent case
08/18/2004CN1521269A Method for detecting nucleic acid based on hybridization trapping in single tube
08/18/2004CN1521268A Method for detecting childhood absence epilepsy major gene CACNA1H mutant gene and CACNA1H mutant gene
08/18/2004CN1521267A Method for detecting recombinant human hepatocyte growth factor activity
08/18/2004CN1521266A Pathogenic microorganism infection diagnosis type cell chip and method for preparing the same
08/18/2004CN1521263A PCR method
08/18/2004CN1521180A Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/18/2004CN1162705C Method of screening medicine for inhibiting or promoting new angiopoiesis
08/18/2004CN1162699C 生物传感器 Biosensor
08/18/2004CN1162552C Detection method for enzyme label signal in gene chip
08/18/2004CN1162551C Pretreating liquid for tubercle bacillus sputum specimen and its application
08/18/2004CN1162550C Method for preparing pleurotu ostreatus drug-sensitive culture medium
08/18/2004CN1162549C Biphase fast culture medium for tubercle bacillus and preparation method thereof
08/18/2004CN1162547C Hepatitis B virus antisense RNA expression vector targeting liver cancer and its construction process and use
08/18/2004CN1162545C Cathepsin B gene of Helicoverpa armigera and its cloning, recombining and expressing technique
08/18/2004CN1162444C Specific primer sequence of cattle Y-chromosome
08/17/2004US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them
08/17/2004US6777247 Nervous necrosis virus protein
08/17/2004US6777243 Measuring detectable substance by using aqueous reaction system including formation reaction of detectable substance based on chemical reaction of analyte contained in sample; reacting in presence of layered inorganic compound
08/17/2004US6777239 Analysis of preferential polypeptide in sample; obtain sample polypeptide, incubate with antibody bound solid support, detect signal, recover bound polypeptide
08/17/2004US6777228 Detection of air borne particles that have sizes consistent with certain hazardous biological pathogens that can be used as biological warfare agents
08/17/2004US6777226 Sensor device for detecting microorganisms, and method therefor
08/17/2004US6777210 Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1
08/17/2004US6777201 Method for the determination of the concentration of micro-organisms
08/17/2004US6777200 Kinesin motor modulators derived from the marine sponge Adocia
08/17/2004US6777199 Rapid quantitative measurement of soluble fibrin in opaque body fluids
08/17/2004US6777197 By detecting the amount of unbound amylase, deducing the detected amount of unbound amylase from the known concentration of amylase to determine the amount of immunoglobulin specifically bound to the amylase
08/17/2004US6777192 Contacting the sample with an isolated recombinant immunodominant neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
08/17/2004US6777189 Generating preferential oligonucleotides; obtain nucleotide sequences, incubate with polymerase, amplify, expose to chain terminating enzyme, recover oligonucleotides
08/17/2004US6777188 Determining the genotype of diploid organism; obtain alleles of target genes, incubate with primers, amplify, detect signal, classify hybridization pattern
08/17/2004US6777187 Genome walking by selective amplification of nick-translate DNA library and amplification from complex mixtures of templates
08/17/2004US6777186 Nanoparticles having oligonucleotides attached thereto and uses therefor
08/17/2004US6777185 Functional genomics using zinc finger proteins
08/17/2004US6777184 Detection of nucleic acid hybridization by fluorescence polarization
08/17/2004US6777183 Process for allele discrimination utilizing primer extension
08/17/2004US6777182 Methods for determining the likelihood of endometriosis in a female subject
08/17/2004US6777181 Method for separating and collecting nucleic acids
08/17/2004US6777180 Isolating a double- stranded cdna having a nucleotide sequence of a complete open reading frame
08/17/2004US6777179 Drug screening for an antiviral agent, viricides; genetic engineering
08/17/2004US6776965 Include features that can enhance performance of the fluid transfer, referred to a pre-shooter stop, a butterfly/a cascade structures, a waste chamber inlet, stop chamber, a bifunctional flow through chamber and hydrophobic vent
08/17/2004US6776960 Including large number of spots of sample solution arranged on base plate by supplying solution from dispenser onto plate, wherein solution is supplied a plurality of times to form one spot and solution is dried, thickened, solidified
08/17/2004US6776959 Nucleic acid stabilizing aqueous solution comprising guanidinium salt, buffer, reducing agent, and detergent
08/17/2004US6776888 Biosensor
08/17/2004CA2325228C Catalytic domain of the human effector cell cycle checkpoint protein kinase, chk1, materials and methods for identification of inhibitors thereof
08/17/2004CA2285377C Improvements in thermal cycler for pcr
08/12/2004WO2004068139A2 Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes
08/12/2004WO2004068115A2 Assay method for group transfer reactions
08/12/2004WO2004068112A2 Hairpin primer amplification
08/12/2004WO2004068111A2 Methods and compositions for rna detection and quantitation
08/12/2004WO2004068110A2 Methods of predicting mortality risk by determining telomere length
08/12/2004WO2004068107A2 Apparatus and method for transcellular testing
08/12/2004WO2004067779A2 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
08/12/2004WO2004067778A2 Differentially expressed genes in large granular lymphocyte leukemia
08/12/2004WO2004067777A1 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the development of peripheral zone prostate cancer
08/12/2004WO2004067776A1 COMPOUNDS AND PROCESSES FOR SINGLE-POT ATTACHMENT OF A LABEL TO siRNA
08/12/2004WO2004067775A2 Method for the detection of cytosine methylation patterns with high sensitivity
08/12/2004WO2004067774A2 Single nucleotide polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
08/12/2004WO2004067773A1 Screening assay based on rhe sod-3 promotor for the identification of compounds modulating akt or upstream regulators such as insulin/igf-1 receptors
08/12/2004WO2004067772A1 Method for the identification and isolation of strong bacterial promoters
08/12/2004WO2004067771A1 Association of the gys1 genotype with increased risk for diabetes mellitus type 2
08/12/2004WO2004067770A1 Active dna nanocompartment and its preparation
08/12/2004WO2004067769A1 The method of detecting the cacna1h mutant gene of childhood absence epilepsy-the main function gene, and the cacna1h mutant gene
08/12/2004WO2004067768A2 Improved method for the detection of proteolytic enzymes
08/12/2004WO2004067767A1 Method of screening cell death modulators.
08/12/2004WO2004067766A1 Novel methods involving the determination of activity of enzymes that use or produce prostaglandin endoperoxide h2
08/12/2004WO2004067765A2 Organism fingerprinting using nicking agents
08/12/2004WO2004067764A2 Nucleic acid sequencing using nicking agents
08/12/2004WO2004067763A2 Genetic diagnosis of alcoholism subtypes
08/12/2004WO2004067759A2 Replication of nucleic acid arrays
08/12/2004WO2004067758A2 Production of 5'-ribonucleotides
08/12/2004WO2004067741A1 Transcriptional activator
08/12/2004WO2004067740A1 Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (ldl-r) which is associated with familial hypercholesterolemia
08/12/2004WO2004067726A2 Isothermal reactions for the amplification of oligonucleotides
08/12/2004WO2004067722A2 Facls as modifiers of the rb pathway and methods of use
08/12/2004WO2004067721A2 Tkts as modifiers of the beta-catenin pathway and methods of use
08/12/2004WO2004067720A2 Systems and methods for predicting specific genetic loci that affect phenotypic traits
08/12/2004WO2004067715A2 Anonymous testing system and kit
08/12/2004WO2004067702A2 Methods, oligonucleotides and kits for the identification of mycobacterium in a sample
08/12/2004WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen
08/12/2004WO2004067545A1 Improved method for bisulfite treatment
08/12/2004WO2004067032A2 Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes
08/12/2004WO2004066961A2 Use of sendai virus as a human parainfluenza vaccine
08/12/2004WO2004066949A2 Antisense oligonucleotides that inhibit expression of hif-1
08/12/2004WO2004066948A2 Mapcaxs as modifiers of the apc and axin pathways and methods of use
08/12/2004WO2004066943A2 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin
08/12/2004WO2004066941A2 Expression profiles for colon cancer and methods of use
08/12/2004WO2004066940A2 Compositions and methods containing substituted quinolines and substituted diphenylsulfones
08/12/2004WO2004066935A2 Sensitive proteasome sensor constructs and methods for their design and use
08/12/2004WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1
08/12/2004WO2004066926A2 Methods and compositions for modulating t lymphocytes
08/12/2004WO2004066924A2 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
08/12/2004WO2004066917A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites